Agilon Health, Inc. (AGL) has a consensus analyst rating of Hold, based on 25 analysts covering the stock. Of those, 6 recommend buying, 17 recommend holding, and 2 recommend selling.
The analyst consensus price target for AGL is $3.51, representing a -84.5% downside from the current price of $22.68. Price targets range from a low of $1.10 to a high of $6.50.
